BOSTON / Feb 22, 2023 / Business Wire / Ovia Health, a trusted digital health platform for women and families, today announced the expansion of its Ovia® app, which will now allow women to track menopause symptoms and access valuable resources and support to address the transition to menopause/perimenopause. The technology is available through Ovia’s consumer application and enterprise offerings for employers and health plans.
According to the National Institute on Aging (NIA), more than 1 million women transition through menopause annually while millions more transition through perimenopause or post-menopause stages, all of which cause many women to experience symptoms ranging from mild to debilitating impact. And, we know that far too many women currently don’t receive information to help them through this period of transition. The Ovia Health app digital expansion is designed to give women access to information and resources about the menopause, perimenopause and post-menopause transition and complements Ovia Health’s Ovia Fertility, Ovia Pregnancy and Ovia Parenting digital platforms, bringing women a lifetime worth of valuable health information unique to their needs. Ovia Health is a wholly owned subsidiary of Labcorp, a leader in women’s health. Labcorp offers a full range of provider-ordered tests and consumer direct purchase tests to support women in their pursuit of health answers for themselves and their families.
“For far too long, women and the broader healthcare community have not openly discussed the topic of menopause or perimenopause, a transition in life that can create a significant impact in the lives of women,” said Dr. Leslie Saltzman, chief medical officer of Ovia Health. “By expanding a platform used by hundreds of thousands of women, we are bringing this much-needed conversation to the forefront in a way that provides women access to information and resources during a pivotally important time. Women will be more empowered to have conversations with their healthcare providers in a way that helps them better understand and assess their healthcare needs.”
The expanded digital platform now offers new functionality to help women be better informed and have greater control of their own health. Users will be able to access:
With the addition of the menopause digital platform, Ovia serves as a full-spectrum resource, better able to support women’s unique healthcare needs through their existing health plans and employers’ benefits programs.
To learn more about the Ovia Menopause digital platform, visit here.
About Ovia Health
Ovia Health, a Labcorp subsidiary, has served more than 17 million family and parenthood journeys since 2012 and is on a mission to make a happy, healthy family possible for everyone. Ovia Health is the only family health solution clinically proven to effectively identify and intervene with high-risk conditions. The company's 50+ clinical programs, including predictive coaching and personalized care plans, help prevent unnecessary health care costs, improve health outcomes, and foster a family-friendly workplace that increases retention and return to work. For more information, visit OviaHealth.com.
Last Trade: | US$259.12 |
Daily Change: | -0.88 -0.34 |
Daily Volume: | 144,909 |
Market Cap: | US$21.670B |
April 29, 2025 April 02, 2025 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load